+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Tissue Diagnostic Market Research Report by Product (Accessories and Instruments), Technology, Application, End-User, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 4989888
  • Report
  • April 2022
  • Region: Global
  • 209 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Agilent Technologies Inc
  • Bio SB
  • bioMerieux Inc.
  • Danaher Corporation
  • Histoline Laboratories
The Global Tissue Diagnostic Market size was estimated at USD 5,062.69 million in 2021, USD 5,441.55 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.66% to reach USD 7,883.51 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Tissue Diagnostic to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Product, the market was studied across Accessories and Instruments.
  • Based on Technology, the market was studied across Digital Pathology and Workflow, Immunohistochemistry, In Situ Hybridization, and Special Staining.
  • Based on Application, the market was studied across Breast Cancer, Gastric Cancer, Lymphoma, Non Small Cell Lung Cancer, and Prostate Cancer.
  • Based on End-User, the market was studied across Contract Research Organization (CRO), Hospitals, Pharmaceutical Organizations, and Research Laboratories.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Tissue Diagnostic market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Tissue Diagnostic Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Tissue Diagnostic Market, including Abbott Laboratories Inc, ABCAM PLC, Agilent Technologies Inc, Amos Scientific PTY Ltd, Becton Dickinson & Company, Bio SB, Bio-Rad Laboratories Inc, Biogenex Laboratories Inc, bioMerieux Inc., Cell Signalling Technology, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd, Histoline Laboratories, Johnson & Johnson, Merck KGaA, Pfizer Inc, QIAGEN N.V., Sakura Finetek Japan Co.,Ltd., Siemens Healthineers AG, Slee Medical GMBH, and Thermo Fisher Scientific Inc.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Tissue Diagnostic Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Tissue Diagnostic Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Tissue Diagnostic Market?
4. What is the competitive strategic window for opportunities in the Global Tissue Diagnostic Market?
5. What are the technology trends and regulatory frameworks in the Global Tissue Diagnostic Market?
6. What is the market share of the leading vendors in the Global Tissue Diagnostic Market?
7. What modes and strategic moves are considered suitable for entering the Global Tissue Diagnostic Market?
Frequently Asked Questions about the Global Tissue Diagnostic Market

What is the estimated value of the Global Tissue Diagnostic Market?

The Global Tissue Diagnostic Market was estimated to be valued at $5062.7 Million in 2021.

What is the growth rate of the Global Tissue Diagnostic Market?

The growth rate of the Global Tissue Diagnostic Market is 7.6%, with an estimated value of $7883.5 Million by 2027.

What is the forecasted size of the Global Tissue Diagnostic Market?

The Global Tissue Diagnostic Market is estimated to be worth $7883.5 Million by 2027.

Who are the key companies in the Global Tissue Diagnostic Market?

Key companies in the Global Tissue Diagnostic Market include Abbott Laboratories Inc, ABCAM PLC, Agilent Technologies Inc, Amos Scientific PTY Ltd, Becton Dickinson & Company, Bio SB, Bio, Rad Laboratories Inc and bioMerieux Inc..
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbott Laboratories Inc
  • Agilent Technologies Inc
  • Bio SB
  • bioMerieux Inc.
  • Danaher Corporation
  • Histoline Laboratories

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing incidence of cancer
5.1.1.2. Growing use of personalized medicine
5.1.1.3. Inception of automated tissue diagnostics to enhance assay performance and minimize the number of pathologists
5.1.2. Restraints
5.1.2.1. High cost involved in tissue diagnosis and reimbursement issues
5.1.3. Opportunities
5.1.3.1. Innovation in diagnostic testing for highly efficient testing
5.1.3.2. Government initiatives to increase awareness regarding effective and early cancer diagnosis
5.1.3.3. Rising investments in research and development of new technologies
5.1.4. Challenges
5.1.4.1. Strict regulatory framework for approval of devices
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Tissue Diagnostic Market, by Product
6.1. Introduction
6.2. Accessories
6.3. Instruments
7. Tissue Diagnostic Market, by Technology
7.1. Introduction
7.2. Digital Pathology and Workflow
7.3. Immunohistochemistry
7.4. In Situ Hybridization
7.5. Special Staining
8. Tissue Diagnostic Market, by Application
8.1. Introduction
8.2. Breast Cancer
8.3. Gastric Cancer
8.4. Lymphoma
8.5. Non Small Cell Lung Cancer
8.6. Prostate Cancer
9. Tissue Diagnostic Market, by End-User
9.1. Introduction
9.2. Contract Research Organization (CRO)
9.3. Hospitals
9.4. Pharmaceutical Organizations
9.5. Research Laboratories
10. Americas Tissue Diagnostic Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Tissue Diagnostic Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
12. Europe, Middle East & Africa Tissue Diagnostic Market
12.1. Introduction
12.2. France
12.3. Germany
12.4. Italy
12.5. Netherlands
12.6. Qatar
12.7. Russia
12.8. Saudi Arabia
12.9. South Africa
12.10. Spain
12.11. United Arab Emirates
12.12. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.1.1. Quadrants
13.1.2. Business Strategy
13.1.3. Product Satisfaction
13.2. Market Ranking Analysis
13.3. Market Share Analysis, By Key Player
13.4. Competitive Scenario
13.4.1. Merger & Acquisition
13.4.2. Agreement, Collaboration, & Partnership
13.4.3. New Product Launch & Enhancement
13.4.4. Investment & Funding
13.4.5. Award, Recognition, & Expansion
14. Company Usability Profiles
14.1. Abbott Laboratories Inc
14.2. ABCAM PLC
14.3. Agilent Technologies Inc
14.4. Amos Scientific PTY Ltd
14.5. Becton Dickinson & Company
14.6. Bio SB
14.7. Bio-Rad Laboratories Inc
14.8. Biogenex Laboratories Inc
14.9. bioMerieux Inc.
14.10. Cell Signalling Technology, Inc.
14.11. Danaher Corporation
14.12. F. Hoffmann-La Roche Ltd
14.13. Histoline Laboratories
14.14. Johnson & Johnson
14.15. Merck KGaA
14.16. Pfizer Inc
14.17. QIAGEN N.V.
14.18. Sakura Finetek Japan Co.,Ltd.
14.19. Siemens Healthineers AG
14.20. Slee Medical GMBH
14.21. Thermo Fisher Scientific Inc
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL TISSUE DIAGNOSTIC MARKET: DYNAMICS
FIGURE 2. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2027
FIGURE 5. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (%)
FIGURE 10. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2027
FIGURE 12. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, 2019-2027 (USD MILLION)
FIGURE 17. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 18. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, 2019-2027 (USD MILLION)
FIGURE 19. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 20. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (%)
FIGURE 21. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2021 VS 2027 (USD MILLION)
FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2027
FIGURE 23. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, 2019-2027 (USD MILLION)
FIGURE 24. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 25. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, 2019-2027 (USD MILLION)
FIGURE 26. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 27. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, 2019-2027 (USD MILLION)
FIGURE 28. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 29. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, 2019-2027 (USD MILLION)
FIGURE 30. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 31. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, 2019-2027 (USD MILLION)
FIGURE 32. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 33. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2021 VS 2027 (%)
FIGURE 34. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2021 VS 2027 (USD MILLION)
FIGURE 35. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2027
FIGURE 36. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), 2019-2027 (USD MILLION)
FIGURE 37. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 38. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2019-2027 (USD MILLION)
FIGURE 39. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 40. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, 2019-2027 (USD MILLION)
FIGURE 41. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 42. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, 2019-2027 (USD MILLION)
FIGURE 43. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 44. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 47. CANADA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 48. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 49. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 50. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 51. AUSTRALIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 52. CHINA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 53. INDIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 54. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 55. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 56. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 57. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 58. SINGAPORE TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 59. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 60. TAIWAN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 61. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 62. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 63. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 64. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 65. ITALY TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 66. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 67. QATAR TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 68. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 69. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 70. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 71. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 72. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 73. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 74. GLOBAL TISSUE DIAGNOSTIC MARKET: FPNV POSITIONING MATRIX
FIGURE 75. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 76. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL TISSUE DIAGNOSTIC MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL TISSUE DIAGNOSTIC MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PRODUCT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY DIGITAL PATHOLOGY AND WORKFLOW, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY IMMUNOHISTOCHEMISTRY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 26. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 27. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 28. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 29. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY IN SITU HYBRIDIZATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 30. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY REGION, 2019-2027 (USD MILLION)
TABLE 31. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 32. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY STATE, 2019-2027 (USD MILLION)
TABLE 33. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 34. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY SPECIAL STAINING, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 35. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY APPLICATION, 2019-2027 (USD MILLION)
TABLE 36. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 37. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 38. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 39. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 40. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY BREAST CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 41. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 42. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 43. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 44. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 45. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY GASTRIC CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 46. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY REGION, 2019-2027 (USD MILLION)
TABLE 47. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 48. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY STATE, 2019-2027 (USD MILLION)
TABLE 49. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 50. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY LYMPHOMA, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 51. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 52. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 53. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 54. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 55. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY NON SMALL CELL LUNG CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 56. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2019-2027 (USD MILLION)
TABLE 57. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 58. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY STATE, 2019-2027 (USD MILLION)
TABLE 59. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 60. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY PROSTATE CANCER, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 61. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY END-USER, 2019-2027 (USD MILLION)
TABLE 62. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY REGION, 2019-2027 (USD MILLION)
TABLE 63. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 64. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY STATE, 2019-2027 (USD MILLION)
TABLE 65. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 66. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATION (CRO), BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 67. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY REGION, 2019-2027 (USD MILLION)
TABLE 68. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 69. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY STATE, 2019-2027 (USD MILLION)
TABLE 70. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 71. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 72. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY REGION, 2019-2027 (USD MILLION)
TABLE 73. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 74. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY STATE, 2019-2027 (USD MILLION)
TABLE 75. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 76. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY PHARMACEUTICAL ORGANIZATIONS, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 77. GLOBAL TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 78. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 79. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 80. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, BY RESEARCH LABORATORIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 82. AMERICAS TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 83. ARGENTINA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 84. BRAZIL TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 85. CANADA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 86. MEXICO TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 87. UNITED STATES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 88. ASIA-PACIFIC TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 89. AUSTRALIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 90. CHINA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 91. INDIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 92. INDONESIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 93. JAPAN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 94. MALAYSIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 95. PHILIPPINES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 96. SINGAPORE TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 97. SOUTH KOREA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 98. TAIWAN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 99. THAILAND TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 101. FRANCE TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 102. GERMANY TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 103. ITALY TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 104. NETHERLANDS TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 105. QATAR TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 106. RUSSIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 107. SAUDI ARABIA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 108. SOUTH AFRICA TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 109. SPAIN TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 110. UNITED ARAB EMIRATES TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 111. UNITED KINGDOM TISSUE DIAGNOSTIC MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 112. GLOBAL TISSUE DIAGNOSTIC MARKET: SCORES
TABLE 113. GLOBAL TISSUE DIAGNOSTIC MARKET: BUSINESS STRATEGY
TABLE 114. GLOBAL TISSUE DIAGNOSTIC MARKET: PRODUCT SATISFACTION
TABLE 115. GLOBAL TISSUE DIAGNOSTIC MARKET: RANKING
TABLE 116. GLOBAL TISSUE DIAGNOSTIC MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 117. GLOBAL TISSUE DIAGNOSTIC MARKET: MERGER & ACQUISITION
TABLE 118. GLOBAL TISSUE DIAGNOSTIC MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 119. GLOBAL TISSUE DIAGNOSTIC MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 120. GLOBAL TISSUE DIAGNOSTIC MARKET: INVESTMENT & FUNDING
TABLE 121. GLOBAL TISSUE DIAGNOSTIC MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 122. GLOBAL TISSUE DIAGNOSTIC MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • Abbott Laboratories Inc
  • ABCAM PLC
  • Agilent Technologies Inc
  • Amos Scientific PTY Ltd
  • Becton Dickinson & Company
  • Bio SB
  • Bio-Rad Laboratories Inc
  • Biogenex Laboratories Inc
  • bioMerieux Inc.
  • Cell Signalling Technology, Inc.
  • Danaher Corporation
  • F. Hoffmann-La Roche Ltd
  • Histoline Laboratories
  • Johnson & Johnson
  • Merck KGaA
  • Pfizer Inc
  • QIAGEN N.V.
  • Sakura Finetek Japan Co.,Ltd.
  • Siemens Healthineers AG
  • Slee Medical GMBH
  • Thermo Fisher Scientific Inc
Note: Product cover images may vary from those shown

Loading
LOADING...